AI-powered ECG Analysis for Deadly Arrhythmias and ICI Myocarditis
Recruiting
Observational Study
Arrhythmia
Long QT Syndrome
Immune Checkpoint Inhibitor-Related Myocarditis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 127,000 (estimated)
- Sponsor
- Groupe Hospitalier Pitie-Salpetriere · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
ELDORA is a non-interventional observational data-science study aiming to develop and validate clinical-grade artificial intelligence tools applied to electrocardiogram (ECG) data. The project will standardize heterogeneous ECGs, create the ECGInsight harmonized database, and train interpretable models for life-threatening arrhythmia risk prediction, especially Torsades-de-Pointes/long QT syndrome…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* subjects included in participating existing or ongoing ECG cohorts made available to ECGInsight
* availability of ECG data (digital waveform or scanned/paper ECG suitable for digitization) and relevant clinical/demographic metadata
* data use permitted by applicable ethical, r…
Contacts